Skip to main content
. 2021 Feb 1;12:723. doi: 10.1038/s41467-021-20962-6

Fig. 5. MSC-derived IL-28 directs PCa apoptosis.

Fig. 5

a PAIII growth (F0) in response to treatment with MSC CM, heat-inactivated (HI) MSC CM, or proteinase-K (PK) treated MSC CM. b Cytokine Array of MSC CM. Black box indicates positive control (+ve), red box indicates IL-28. c RT-PCR analysis of PAIII (F0 and F2) of IL28Rα, IL-10Rβ and IL-28 expression. Molecular weights in base pairs are shown. d Growth of PAIII (F0) in MSC CM immune-depleted of IL-28 (MSC αIL-28). IgG was used as negative control (MSC IgG). Growth is expressed as a percentage of non-treated cells. e Treatment of PAIII F0 and F2 cell lines with the indicated concentrations of recombinant IL-28 (rIL-28) for 48 h. f Growth of IL-28Rα silenced (sh-IL28R) and scrambled control (sh-SCR) compared to parental PAIII cell lines. g, h Control (sh-SCR) and IL-28Rα (sh-IL28R) PAIII and DU145 growth in MSC CM or rIL-28 as measured by luminescence assay and relative light unit (RLU) measurement or MTT assay. Experiments were repeated on at least two (c, f, h) or three (a, ei) occasions. Error bars represent the mean ± SEM. Statistical analyses were performed by one-way ANOVA with multiple comparisons at 95% CI (a, g, i) or unpaired t-test (e, f, h). Asterisks denotes statistical significance (**p ≤ 0.01, ****p ≤ 0.0001) while NS denotes not significant.